about
Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapyBaseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses.A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging.CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity.Identification of conserved and HLA promiscuous DENV3 T-cell epitopes.Neuroblastoma and dendritic cell function.IL-18-induced CD83+CCR7+ NK helper cellsEnhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1.Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T CellsLinked in: immunologic membrane nanotube networksFc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal diseaseSafety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function.Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4+ T cells.Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes.Cytolytic cells induce HMGB1 release from melanoma cell lines.Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.HIV's ticket to ride: Cytotoxic T-lymphocyte-activated dendritic cells exploited for virus intercellular transfer.The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8⁺ T cell responses.TZA: a novel assay for measuring the latent HIV-1 reservoir.Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination.Tunneling Nanotubes and Gap Junctions-Their Role in Long-Range Intercellular Communication during Development, Health, and Disease Conditions.Naive CD8+ T cells from ART respond to primary vaccination against autologous HIV-1 antigen.Safety and Immunogenicity of Zoster Vaccine Live in HIV-Infected Adults with CD4+ Cell Counts Above 200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+ T cells in the lesional skin of a patient with melanoma-related depigmentation.Detection of IgG3 antibodies specific to the human immunodeficiency virus type 1 (HIV-1) p24 protein as marker for recently acquired infectionType 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivoAdvanced neuroblastoma impairs dendritic cell function in adoptive immunotherapyDendritic cells promote T-cell survival or death depending upon their maturation state and presentation of antigenDendritic cells pulsed with apoptotic squamous cell carcinoma have anti-tumor effects when combined with interleukin-2alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activityContrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell FunctionsRole of Dendritic Cells in Exposing Latent HIV-1 for the KillCD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infection
P50
Q28475576-3336CE7B-B454-40A8-ACF8-57321E62EC9CQ33572705-6B11663E-532F-4CB0-B9B6-B0419D6806DDQ33572705-E77D585C-FF70-4000-BA50-B00B2FD90F8FQ34059416-E40FD873-28B2-4357-98E1-6F98F6A25361Q34114993-BCA0A03E-1D66-4643-913E-C214BD33F6BDQ34892779-C0D503F9-EBEE-47CF-B96A-06041C2B4808Q34980344-0697F78D-1D9F-41FC-B9B6-3F57D6C5A865Q35018972-2F60CCBE-F716-4351-955E-0D214835FE9CQ35650033-FA1A13C1-E459-4240-88A0-842B3CE9FAD4Q36403560-94EB4230-D28E-4412-ACAC-DA68F86D69E4Q36656025-559A0B4D-3677-4F6A-B3CE-A6CB5E297660Q36974205-ADFF4EF9-3EEC-4041-9076-6E21E49D9233Q37098075-E787DCFB-93C9-45D5-8B04-96DA33D0960EQ37140093-53B5AAE5-ADD4-4392-8686-BC16E436EF2AQ37381097-B3251F77-5813-4C89-8E03-99F41F28FB2DQ39666393-ADFB4331-F6FF-43FB-B76E-5373867955AFQ39824406-F2399752-1462-408F-8F6A-884489805940Q40182056-E3D86472-5474-45F5-946E-DD139F3871D6Q40207674-8EA1C2B3-F9E6-4FFE-BFC7-84030EA90F46Q40232947-663F6666-D310-4BA5-9C56-6BE26969FCE2Q40240423-76AB614A-EE51-4305-BB23-D66E44760532Q41685331-32295F20-2DB4-409B-A73D-BE48A6643D51Q41981778-4E82A7C0-3F1B-40D6-9758-2EA1366594FAQ41995271-A81E95E6-80E9-488D-B81D-FF79C01AF86DQ42238546-73C2C7AE-0D04-431D-8458-C14B2FC92FAAQ45723587-B0C0ED94-7EB2-4815-9032-F5660F84D8E0Q45911579-C5E44ADD-C937-4872-AF46-E772FB561294Q52723555-BC4A8DCB-88FC-4431-B3E5-0FFD8CD0692DQ54611706-E73136E0-D993-4AEB-8511-B32E3252C55EQ59358413-1E5B878A-6312-4B4B-991B-92328E52B97FQ64972216-0804EB47-C69B-46C6-866F-9E652F65EBE0Q73114649-F7E9126D-C31E-4CCC-8A32-67622D570E89Q73460728-3F95CBA3-B792-45F6-888B-364F9CDE2968Q73896935-DB279061-50CB-485F-9520-D7029DCA1234Q74544147-96FE1787-BFA3-4631-8805-C58C8A12C57BQ80516665-22F30E4C-1C3D-4ED1-8BC5-A4231E437C23Q90434858-71EECC15-FD20-499A-94C0-B907615BB9B5Q92441659-ACC972E5-5E11-44B2-994D-BE842073B5BEQ92524713-A9159C61-2A4E-48F1-BD24-9CC2FB03BACB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Robbie B Mailliard
@nl
Robbie B Mailliard
@sl
Robbie B. Mailliard
@en
Robbie B. Mailliard
@es
type
label
Robbie B Mailliard
@nl
Robbie B Mailliard
@sl
Robbie B. Mailliard
@en
Robbie B. Mailliard
@es
prefLabel
Robbie B Mailliard
@nl
Robbie B Mailliard
@sl
Robbie B. Mailliard
@en
Robbie B. Mailliard
@es
P106
P1153
6603385313
P1960
Y9SfH0UAAAAJ
P21
P31
P496
0000-0001-5501-503X